Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

Filtra i risultati della ricerca
Seleziona modelli di dati

Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

1 Risultati di ricerca.

Modified Hoehn And Yahr Parkinson’s Disease Staging Screening Ropinirole Parkinson Disease 101468/165 - Modified Hoehn And Yahr Parkinson’s Disease Staging Screening

- 16/10/17 - 1 modulo, 1 ItemGroup, 4 elementi, 1 linguaggio

ItemGroup: Modified Hoehn and Yahr Staging

Study Part: Modified Hoehn And Yahr Parkinson’s Disease Staging Screening. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial

Keywords

Sommario

Modelli di dati selezionati

Modified Hoehn And Yahr Parkinson’s Disease Staging Screening Ropinirole Parkinson Disease 101468/165 - Modified Hoehn And Yahr Parkinson’s Disease Staging Screening

Keywords

Sommario

Modelli di dati selezionati

Modified Hoehn And Yahr Parkinson’s Disease Staging Screening Ropinirole Parkinson Disease 101468/165 - Modified Hoehn And Yahr Parkinson’s Disease Staging Screening

Contatto

Aiuto